Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple ascending doses of QBM076 in patients with COPD
2012-005615-92Phase 2Terminated
- Sponsor
- Novartis
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing QBM076 arm with Placebo arm (2 arms). Primary endpoints: Safety and tolerability of multiple ascending doses of QBM076 (Part 1) and Pharmacokinetics of QBM076. Started Sep 2013; status: terminated.
02
Drugs
qbm-076
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-005615-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005615-92.